| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.11B | -10.8% |
| Cost of Revenue | $49.72B | -9.1% |
| Gross Profit | $3.39B | -30.0% |
| R&D Expense | $30.0M | -14.3% |
| SG&A Expense | $1.78B | +3.6% |
| Interest Expense | $471.0M | -8.7% |
| Pre-tax Income | $1.52B | -50.0% |
| Income Tax | $336.0M | -52.9% |
| Net Income | $1.14B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.31B | +27.2% |
| Short-term Investments | $484.0M | +361.0% |
| Accounts Receivable | $2.15B | -17.1% |
| Inventory | $6.49B | -8.6% |
| Current Assets | $15.96B | -2.4% |
| Total Assets | $24.90B | -1.9% |
| Current Liabilities | $7.43B | -3.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.90B | -42.6% |
| Capital Expenditures | $1.38B | +22.6% |
| Investing Cash Flow | -$1.11B | -10.4% |
| Financing Cash Flow | -$90.0M | +89.5% |
| Free Cash Flow | $524.0M | -76.0% |
| -49.3% |
| EPS (Basic) | $8.09 | -46.3% |
| EPS (Diluted) | $7.99 | -46.3% |
| Long-term Debt |
| $5.36B |
| +31.3% |
| Stockholders' Equity | $9.91B | -8.6% |